← Back to Search

Nurse Navigator Program for High-Risk Hospital Patients

N/A

Waitlist Available

Led By George Pujalte, MD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Require total or partial hip or knee replacement and have one or more of the following diagnosis: Heart Failure (HF); Chronic obstructive pulmonary disease (COPD); Dialysis; Alcohol Abuse; Low BMI.

Be older than 18 years old

Must not have

Decrease cognitive capacity to consent to the study.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if an educational program can reduce hospital readmissions and patient satisfaction in high risk patients.

Who is the study for?

This trial is for patients needing hip or knee replacement surgery who also have heart failure, COPD, require dialysis, abuse alcohol, or have a low BMI. It's not open to those with reduced ability to consent due to cognitive issues.

What is being tested?

The study tests if a Nurse Navigator Program can reduce hospital readmissions and improve patient satisfaction compared to usual care in high-risk surgical patients.

What are the potential side effects?

Since this is an educational program rather than a medication, traditional side effects are not expected. However, participants may experience varying levels of satisfaction with the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I need a hip or knee replacement and have heart issues, lung problems, need dialysis, have alcohol abuse history, or low BMI.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am unable to understand and agree to the study on my own.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Nurse NavigatorExperimental Treatment1 Intervention

Patients with chronic conditions slated for surgery contacted once by pre-operative nurse to discuss surgery, then contacted at intervals by nurse navigator study team members

Group II: Usual PracticeActive Control1 Intervention

Patients with chronic conditions slated for surgery contacted once by pre-operative nurse to discuss surgery

0 / 2Eligibility criteria met